Gonadotropin Releasing Honnone Agonist and Antagonist for Endometriosis

Robert L. Barbieri

doi:10.1201/b14235-14

Gonadotropin Releasing Honnone Agonist and Antagonist for Endometriosis

Robert L. Barbieri

In: Endometriosis · 2003 · pp. 219–243 · doi:10.1201/b14235-14 · W2503734220

book-chapter OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review examines the efficacy and safety of gonadotropin-releasing hormone agonists and antagonists for treating endometriosis symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
Comparison of the pharmacology of nafarelin and danazol via openalex
Conservative Treatment of Endometriosis: The Effects of Limited Surgery and Hormonal Pseudopregnancy via openalex
Current Concepts of Endometriosis via openalex
Efficacy of Every-Other-Day Administration of Conjugated Equine Estrogen and Medroxyprogesterone Acetate on Gonadotropin-Releasing Hormone Agonists Treatment in Women with Endometriosis via openalex
Endometriosis of the Bowel via openalex
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy via openalex
Gonadotropin-Releasing Hormone and Its Analogues via openalex
Gonadotropin-Releasing Hormone and Its Analogues via openalex
Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
Human uterine endometrium and endometriotic tissue transplanted into nude mice. Morphologic effects of various steroid hormones. via openalex
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
Nafarelin in the Treatment of Endometriosis via openalex
New Therapy for Endometriosis via openalex
Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial via openalex
Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis via openalex
Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex
Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex
Reoperation Rates for Recurrent Ovarian Endometriomas after Surgical Excision via openalex
Spontaneous and steroid-induced recurrence of endometriosis after suppression by a gonadotropin-releasing hormone antagonist in the rat via openalex
Steroidal ‘Add-Back’ Therapy in Patients Treated with GnRH Agonists via openalex
The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian Hormones via openalex
Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy) via openalex
Use of GnRH antagonists in the treatment of endometriosis via openalex
Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
W2033824922 via openalex
W2166833540 via openalex
W2283760758 via openalex
W2338482410 via openalex
W1968933979 via openalex
W2412636952 via openalex
W1618997004 via openalex
W2420303586 via openalex
W1565139074 via openalex
W3022017015 via openalex
W164119867 via openalex
W3124509531 via openalex
W4241378879 via openalex
W73385028 via openalex
W2114058836 via openalex
W4249309457 via openalex
W2121089358 via openalex
W2134221373 via openalex
W2067316892 via openalex
W2048941578 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex

[2] Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex

[3] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[4] Comparison of the pharmacology of nafarelin and danazol via openalex

[5] Conservative Treatment of Endometriosis: The Effects of Limited Surgery and Hormonal Pseudopregnancy via openalex

[6] Current Concepts of Endometriosis via openalex

[7] Efficacy of Every-Other-Day Administration of Conjugated Equine Estrogen and Medroxyprogesterone Acetate on Gonadotropin-Releasing Hormone Agonists Treatment in Women with Endometriosis via openalex

[8] Endometriosis of the Bowel via openalex

[9] Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex

[10] Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy via openalex

[11] Gonadotropin-Releasing Hormone and Its Analogues via openalex

[12] Gonadotropin-Releasing Hormone and Its Analogues via openalex

[13] Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex

[14] Human uterine endometrium and endometriotic tissue transplanted into nude mice. Morphologic effects of various steroid hormones. via openalex

[15] Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex

[16] Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex

[17] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex

[18] Nafarelin in the Treatment of Endometriosis via openalex

[19] New Therapy for Endometriosis via openalex

[20] Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial via openalex

[21] Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex

[22] Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex

[23] Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis via openalex

[24] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex

[25] Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex

[26] Reoperation Rates for Recurrent Ovarian Endometriomas after Surgical Excision via openalex

[27] Spontaneous and steroid-induced recurrence of endometriosis after suppression by a gonadotropin-releasing hormone antagonist in the rat via openalex

[28] Steroidal ‘Add-Back’ Therapy in Patients Treated with GnRH Agonists via openalex

[29] The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian Hormones via openalex

[30] Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy) via openalex

[31] Use of GnRH antagonists in the treatment of endometriosis via openalex

[32] Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex

[33] W2033824922 via openalex

[34] W2166833540 via openalex

[35] W2283760758 via openalex

[36] W2338482410 via openalex

[37] W1968933979 via openalex

[38] W2412636952 via openalex

[39] W1618997004 via openalex

[40] W2420303586 via openalex

[41] W1565139074 via openalex

[42] W3022017015 via openalex

[43] W164119867 via openalex

[44] W3124509531 via openalex

[45] W4241378879 via openalex

[46] W73385028 via openalex

[47] W2114058836 via openalex

[48] W4249309457 via openalex

[49] W2121089358 via openalex

[50] W2134221373 via openalex

[51] W2067316892 via openalex

[52] W2048941578 via openalex